Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc V.VER.H

Alternate Symbol(s):  VRSEF

Verisante Technology, Inc. is a Canada-based company. The Company does not operate any active business other than to identify and complete a reverse takeover (RTO) with a company in one of its target sectors that demonstrates significant growth potential and/or value creation opportunities for shareholders. The Company may pursue a target in any industry, it intends to focus its search on companies that meet its acquisition target characteristics within the life sciences sectors.


TSXV:VER.H - Post by User

Bullboard Posts
Post by AnalyticalTraderon Jan 03, 2012 1:42pm
417 Views
Post# 19366189

Things to be aware of

Things to be aware of

1. The bid prices are set to prey at and profit from shareholders with unrealistic expectations on the stock. 

2. Traders set up the back and fro between 0.66 and 0.70 to play with the minds of newcomers. 

3. Text-book technical analysis suggests that when support is established and visible, it's a right time to buy. 

4. The growth of the sp will be steady and possibly bumpy. Horizon for the endearing 2.60$ target is best set against the first news of contract or order or earning projection. 

5. A new round of media coverage is expected, as the company pursues FDA approval.  

Bullboard Posts